Publication Guidelines(pdf)
Publications:
Cox, et al. (2011) Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.
Hum Mol Genet. 2011 Dec 1;20(23):4732-4747 Epub2011 Sep 2
Mulligan, et al. (2011) Common breast cancer susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
Breast Cancer Res. 2011 Nov 2;13(6):R110 [Epub ahead of print]
Maxwell, et al. (2011) Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer.
PLoS Biol. 2011 Nov;9(11):e1001199. Epub 2011 Nov 15.
Spurdle, et al. (2011) Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers.
Cancer Epidemiology Biomarkers and Prevention 20: 1032-1038 (2011)
Martrat, et al. (2011) Exploring the link between MORF4L1 and risk of breast cancer.
Breast Cancer Research Apr 5;13(2):R40 [Epub ahead of print] (2011)
Osorio, et al (2011) Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers.
Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA) British Journal of Cancer 104, 1356–1361 [Epub] (2011)
Im, et al. (2011) Haplotype Structure in Ashkenazi Jewish BRCA1 and BRCA2 Mutation Carriers.
Human Genetics 2011 May 20; [Epub ahead of print]
Antoniou, et al. (2011) Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.
Human Molecular Genetics 2011 May 18; [Epub ahead of print]
Antoniou, et al. (2010) A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population.
Nature Genetics 42:885-92 (2010)
Engel, et al. (2010) Association of the Variants CASP8 D302H and CASP10 V410I with Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
Cancer Epidemiology Biomarkers and Prevention November 2010 19:2859-2868;
Published Online First October 26 (2010)
Ramus, et al. (2010) Genetic Variation at 9p22.2 modifies ovarian cancer risks in BRCA1 and BRCA2 carriers.
Journal of the National Cancer Institute doi: 10.1093/jnci/djq494 (2010)
Antoniou, et al. (2010) Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers:implications for risk prediction.
Cancer Research 2010 Nov 30; [Epub ahead of print]
Kaufman, et al. (2011) The CYP17A1 -34T>C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Breast Cancer Research and Treatment 126(2)521-7 (2011)
Gaudet, et al. (2010) Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.
PLoS Genet. 2010 October; 6(10): e1001183. Published online 2010 October 28
Walker, et al. (2010) Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers.
Breast Cancer Research 12(6):R102.[Epub ahead of print] (2010)
Wang, et al (2010) Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Hum Mol Genet. 2010 May 14. [Epub ahead of print]
Spurdle, et al. (2009) Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat. 2009 Nov 18. [Epub ahead of print]
Osorio et al. (2009) Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of
Investigators of Modifiers of BRCA1/BRCA2. (CIMBA)
British Journal of Cancer [Epub]
Jakubowska, et al. (2009) The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter
study among 15,542 BRCA1 and BRCA2 mutation carriers.
Breast Cancer Research and Treatment [Epub]
Antoniou, et al. (2009) Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.
Human Molecular Genetics 18(22):4442-56
Sinilnikova, et al. (2009) The TP53 Arg72Pro and MDM2 309G4T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
British Journal of Cancer 101:1456–1460
Johnatty, et al. (2008) No evidence that GATA3 rs570613 SNP modifies breast cancer risk.
Breast Cancer Research and Treatment [Epub]
Osorio, et al. (2008) An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers.
British Journal of Cancer 99(6):974-7
Antoniou, et al. (2008) Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Am J Hum Genet. 82(4):937-48
Rebbeck, et al. (2008) No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study.
Breast Cancer Res Treat [Epub]
Couch, et al. (2007) AURKA F31I Polymorphism and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Consortium of Investigators of Modifiers of BRCA1/2 Study.
Cancer Epidemiol Biomarkers Prev. 16(7):1416-21
Antoniou, et al. (2007) RAD51 135G-->C Modifies Breast Cancer Risk among BRCA2 Mutation Carriers: Results from a Combined Analysis of 19 Studies.
Am J Hum Genet. 81(6):1186-200
Chenevix-Trench, et al. (2007) An international initiative to identify genetic modifiers of BRCA1 and BRCA2: the Consortium of Investigators of
Modifiers of BRCA1 and BRCA2 (CIMBA).
Breast Cancer Research 9(2):104
|
